Evidence map›Paper›PMID 35275353›Full record

ArticleInternational journal of hematology2022

T cell clonal expansion and STAT3 mutations: a characteristic feature of acquired chronic T cell-mediated pure red cell aplasia.

Fumihiro Kawakami, Toru Kawakami, Taku Yamane, Masae Maruyama, Jun Kobayashi, Sayaka Nishina, Hitoshi Sakai, Yumiko Higuchi, Kazutoshi Hamanaka, Makoto Hirokawa and 3 more

Abstract read
PubMed Publisher
In one paragraph

Article in International journal of hematology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed, 2 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 2 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. Review
  16. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Fumihiro KawakamiDivision of Hematology, Department of Internal Medicine, Shinshu University School of Medicine, 3-1-1 Asahi, Matsumoto, Nagano, 3908621, Japan.
Toru KawakamiDivision of Hematology, Department of Internal Medicine, Shinshu University School of Medicine, 3-1-1 Asahi, Matsumoto, Nagano, 3908621, Japan.
Taku YamaneDepartment of Clinical Laboratory Investigation, Graduate School of Medicine, Shinshu University, Matsumoto, Japan.
Masae MaruyamaDepartment of Clinical Laboratory Investigation, Graduate School of Medicine, Shinshu University, Matsumoto, Japan.
Jun KobayashiDepartment of Laboratory Medicine, Nagano Children's Hospital, Azumino, Japan.
Sayaka NishinaDivision of Hematology, Department of Internal Medicine, Shinshu University School of Medicine, 3-1-1 Asahi, Matsumoto, Nagano, 3908621, Japan.
Hitoshi SakaiDivision of Hematology, Department of Internal Medicine, Shinshu University School of Medicine, 3-1-1 Asahi, Matsumoto, Nagano, 3908621, Japan.
Yumiko HiguchiDepartment of Clinical Laboratory Investigation, Graduate School of Medicine, Shinshu University, Matsumoto, Japan.
Kazutoshi HamanakaDepartment of Thoracic Surgery, Shinshu University School of Medicine, Matsumoto, Japan.
Makoto HirokawaDepartment of General Internal Medicine and Clinical Laboratory Medicine Graduate School of Medicine, Akita University, Akita, Japan.
Shinji NakaoDepartment of Hematology, Faculty of Medicine Science, Institute of Medical, Pharmaceutical and Health Sciences, Kanazawa University, Kanazawa, Japan.
Hideyuki Nakazawa *Division of Hematology, Department of Internal Medicine, Shinshu University School of Medicine, 3-1-1 Asahi, Matsumoto, Nagano, 3908621, Japan. fumishi@shinshu-u.ac.jp.ORCID http://orcid.org/0000-0002-6457-5052
Fumihiro Ishida *Division of Hematology, Department of Internal Medicine, Shinshu University School of Medicine, 3-1-1 Asahi, Matsumoto, Nagano, 3908621, Japan. fumishi@shinshu-u.ac.jp.

Funding

Kaken 20K08709
6 · The paper itself

Abstract

Acquired chronic pure red cell aplasia (PRCA) develops idiopathically or in association with other medical conditions, including T cell large granular lymphocytic leukemia (T-LGLL) and thymoma. T cell dysregulation is considered a cardinal pathogenesis of PRCA, but genetic-phenotypic associations in T cell abnormalities are largely unclear. We evaluated an extended cohort of 90 patients with acquired PRCA, including 26 with idiopathic, 36 with T-LGLL-associated and 15 with thymoma-associated PRCA, for their T cell immuno-phenotypes, clonalities and STAT3 mutations. TCR repertoire skewing of CD8

Indexed as

Leukemia, Large Granular LymphocyticRed-Cell Aplasia, PureSTAT3 Transcription FactorThymomaThymus NeoplasmsCD8-Positive T-LymphocytesHumansMutationReceptors, Antigen, T-CellReceptors, Antigen, T-CellSTAT3 protein, humanSTAT3 Transcription FactorLarge granular lymphocytic leukemiaPure red cell aplasiaSTAT3T cell receptorThymoma

Identifiers

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.